Palisade Bio, Inc. (PALI)

USD 1.75

(-7.89%)

Revenue Summary of Palisade Bio, Inc.

  • Palisade Bio, Inc.'s latest annual revenue in 2023 was 250 Thousand USD , down 0.0% from previous year.
  • Palisade Bio, Inc.'s latest quarterly revenue in 2024 Q1 was - USD , up 100.0% from previous quarter.
  • Palisade Bio, Inc. reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • Palisade Bio, Inc. reported a annual revenue of - USD in annual revenue 2021, down -100.0% from previous year.
  • Palisade Bio, Inc. reported a quarterly revenue of - USD for 2024 Q1, up 100.0% from previous quarter.
  • Palisade Bio, Inc. reported a quarterly revenue of 250 Thousand USD for 2023 Q1, down 0.0% from previous quarter.

Annual Revenue Chart of Palisade Bio, Inc. (2023 - 2006)

Historical Annual Revenue of Palisade Bio, Inc. (2023 - 2006)

Year Revenue Revenue Growth
2023 250 Thousand USD 0.0%
2022 - USD 0.0%
2021 - USD -100.0%
2020 13.52 Thousand USD -12.17%
2019 15.39 Thousand USD -94.08%
2018 260 Thousand USD 0.0%
2017 260 Thousand USD 1500.39%
2016 16.24 Thousand USD 55.96%
2015 10.41 Thousand USD -44.69%
2014 18.83 Thousand USD -82.88%
2013 110 Thousand USD -73.02%
2012 407.7 Thousand USD 4.37%
2011 390.62 Thousand USD -46.74%
2010 733.43 Thousand USD 0.0%
2009 - USD 0.0%
2008 - USD -100.0%
2007 306.05 Thousand USD 15.16%
2006 265.75 Thousand USD 0.0%

Peer Revenue Comparison of Palisade Bio, Inc.

Name Revenue Revenue Difference
Acurx Pharmaceuticals, Inc. - USD -Infinity%
Adaptive Biotechnologies Corporation 170.27 Million USD 99.853%
IO Biotech, Inc. - USD -Infinity%
VYNE Therapeutics Inc. 424 Thousand USD 41.038%
Organovo Holdings, Inc. 109 Thousand USD -129.358%
TNF Pharmaceuticals, Inc. - USD -Infinity%
Lexaria Bioscience Corp. 226.2 Thousand USD -10.518%
Tonix Pharmaceuticals Holding Corp. 7.76 Million USD 96.782%
Aadi Bioscience, Inc. 24.35 Million USD 98.973%
Savara Inc. - USD -Infinity%
Aerovate Therapeutics, Inc. - USD -Infinity%
Rocket Pharmaceuticals, Inc. - USD -Infinity%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
ZyVersa Therapeutics, Inc. - USD -Infinity%
Soligenix, Inc. 839.35 Thousand USD 70.215%
Aptose Biosciences Inc. - USD -Infinity%
NKGen Biotech, Inc. Common Stock - USD -Infinity%
Century Therapeutics, Inc. 2.23 Million USD 88.814%
Eterna Therapeutics Inc. 68 Thousand USD -267.647%
Precision BioSciences, Inc. 48.72 Million USD 99.487%
Axsome Therapeutics, Inc. 270.6 Million USD 99.908%
Kura Oncology, Inc. - USD -Infinity%
Xenetic Biosciences, Inc. 2.53 Million USD 90.157%
Dyadic International, Inc. 2.89 Million USD 91.376%
TScan Therapeutics, Inc. 21.04 Million USD 98.812%
IDEAYA Biosciences, Inc. 23.38 Million USD 98.931%
CytomX Therapeutics, Inc. 101.21 Million USD 99.753%
Autolus Therapeutics plc 1.69 Million USD 85.277%
Eton Pharmaceuticals, Inc. 31.64 Million USD 99.21%
EyePoint Pharmaceuticals, Inc. 46.01 Million USD 99.457%
GRI Bio, Inc. 21.76 Million USD 98.851%
Tenaya Therapeutics, Inc. - USD -Infinity%
IGM Biosciences, Inc. 2.13 Million USD 88.263%
Heron Therapeutics, Inc. 127.04 Million USD 99.803%
SAB Biotherapeutics, Inc. 2.23 Million USD 88.834%
Entero Therapeutics, Inc. - USD -Infinity%
Opthea Limited 261.85 Thousand USD 4.529%
X4 Pharmaceuticals, Inc. - USD -Infinity%
Atara Biotherapeutics, Inc. 8.57 Million USD 97.084%
Pliant Therapeutics, Inc. 1.58 Million USD 84.177%
Ligand Pharmaceuticals Incorporated 131.31 Million USD 99.81%
Surrozen, Inc. - USD -Infinity%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Ovid Therapeutics Inc. 391.69 Thousand USD 36.175%
Sorrento Therapeutics, Inc. 62.83 Million USD 99.602%
Acelyrin, Inc. - USD -Infinity%
Centessa Pharmaceuticals plc 6.85 Million USD 96.352%
Hepion Pharmaceuticals, Inc. - USD -Infinity%
Arcturus Therapeutics Holdings Inc. 157.74 Million USD 99.842%
Syros Pharmaceuticals, Inc. 9.93 Million USD 97.484%
ADMA Biologics, Inc. 258.21 Million USD 99.903%
PureTech Health plc 3.33 Million USD 92.492%
Oncternal Therapeutics, Inc. 785 Thousand USD 68.153%
FibroBiologics, Inc. Common Stock - USD -Infinity%
Barinthus Biotherapeutics plc 802 Thousand USD 68.828%
Kymera Therapeutics, Inc. 78.59 Million USD 99.682%
Synaptogenix, Inc. - USD -Infinity%
Tiziana Life Sciences Ltd - USD -Infinity%
ChromaDex Corporation 83.57 Million USD 99.701%
Inhibikase Therapeutics, Inc. 260.5 Thousand USD 4.031%
Monopar Therapeutics Inc. - USD -Infinity%
Exelixis, Inc. 1.83 Billion USD 99.986%
Akebia Therapeutics, Inc. 194.62 Million USD 99.872%
Better Therapeutics, Inc. - USD -Infinity%
Nurix Therapeutics, Inc. 76.98 Million USD 99.675%
Apellis Pharmaceuticals, Inc. 396.59 Million USD 99.937%
Sangamo Therapeutics, Inc. 176.23 Million USD 99.858%
Seer, Inc. 15.18 Million USD 98.353%
Aridis Pharmaceuticals, Inc. - USD -Infinity%
LAVA Therapeutics N.V. 6.76 Million USD 96.307%
Gritstone bio, Inc. 1.33 Million USD 81.217%
Jasper Therapeutics, Inc. - USD -Infinity%
Avid Bioservices, Inc. 139.91 Million USD 99.821%
Insmed Incorporated 305.2 Million USD 99.918%
Panbela Therapeutics, Inc. - USD -Infinity%
Avalo Therapeutics, Inc. 1.92 Million USD 87.006%
Fate Therapeutics, Inc. 63.53 Million USD 99.607%
MediWound Ltd. 18.68 Million USD 98.662%
BioXcel Therapeutics, Inc. 1.38 Million USD 81.884%
Fortress Biotech, Inc. 84.51 Million USD 99.704%
OmniAb, Inc. 34.16 Million USD 99.268%
Seres Therapeutics, Inc. 126.32 Million USD 99.802%
Zai Lab Limited 266.71 Million USD 99.906%
Revance Therapeutics, Inc. 234.04 Million USD 99.893%
Tarsus Pharmaceuticals, Inc. 17.44 Million USD 98.567%
Veracyte, Inc. 361.05 Million USD 99.931%
Abeona Therapeutics Inc. 3.5 Million USD 92.857%
FibroGen, Inc. 147.75 Million USD 99.831%
Apogee Therapeutics, Inc. - USD -Infinity%
ContextLogic Inc. 287 Million USD 99.913%
Intensity Therapeutics, Inc. - USD -Infinity%
Adial Pharmaceuticals, Inc. - USD -Infinity%
HOOKIPA Pharma Inc. 20.12 Million USD 98.758%
Jazz Pharmaceuticals plc 3.83 Billion USD 99.993%
Entrada Therapeutics, Inc. 129.01 Million USD 99.806%
Cyclacel Pharmaceuticals, Inc. 420 Thousand USD 40.476%
ImmuCell Corporation 17.47 Million USD 98.569%
Fortrea Holdings Inc. 3.1 Billion USD 99.992%
KalVista Pharmaceuticals, Inc. - USD -Infinity%
Jasper Therapeutics, Inc. - USD -Infinity%
Foghorn Therapeutics Inc. 34.15 Million USD 99.268%
Ultragenyx Pharmaceutical Inc. 434.24 Million USD 99.942%
Theravance Biopharma, Inc. 57.42 Million USD 99.565%
Metagenomi, Inc. Common Stock 44.75 Million USD 99.441%
Vaxxinity, Inc. - USD -Infinity%
BioCryst Pharmaceuticals, Inc. 331.41 Million USD 99.925%
Gain Therapeutics, Inc. 55.18 Thousand USD -353.063%
Creative Medical Technology Holdings, Inc. 9000.00 USD -2677.778%
Marker Therapeutics, Inc. 3.31 Million USD 92.45%
CASI Pharmaceuticals, Inc. 33.87 Million USD 99.262%
Senti Biosciences, Inc. 2.56 Million USD 90.238%
BioRestorative Therapies, Inc. 145.8 Thousand USD -71.468%
Apollomics, Inc. 821 Thousand USD 69.549%
89bio, Inc. - USD -Infinity%
Arrowhead Pharmaceuticals, Inc. 240.73 Million USD 99.896%
TransCode Therapeutics, Inc. - USD -Infinity%
RAPT Therapeutics, Inc. - USD -Infinity%
Ardelyx, Inc. 124.45 Million USD 99.799%
Pluri Inc. 326 Thousand USD 23.313%
Prothena Corporation plc 91.37 Million USD 99.726%
Pulmatrix, Inc. 7.29 Million USD 96.574%
Celularity Inc. 22.77 Million USD 98.902%
MeiraGTx Holdings plc 14.01 Million USD 98.216%
Omeros Corporation - USD -Infinity%
Ainos, Inc. 122.11 Thousand USD -104.73%
Humacyte, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 95.764%
Cocrystal Pharma, Inc. - USD -Infinity%
Cidara Therapeutics, Inc. 63.9 Million USD 99.609%
Blueprint Medicines Corporation 249.38 Million USD 99.9%
Cabaletta Bio, Inc. - USD -Infinity%
Summit Therapeutics Inc. - USD -Infinity%
Alaunos Therapeutics, Inc. 5000.00 USD -4900.0%
Scholar Rock Holding Corporation - USD -Infinity%
Intellia Therapeutics, Inc. 36.27 Million USD 99.311%
Adlai Nortye Ltd. American Depositary Shares 4.99 Million USD 94.996%
Cytokinetics, Incorporated 7.53 Million USD 96.68%
Eloxx Pharmaceuticals, Inc. - USD -Infinity%
Nutriband Inc. 2.08 Million USD 88.011%
Protara Therapeutics, Inc. - USD -Infinity%
Roivant Sciences Ltd. 124.79 Million USD 99.8%
Evogene Ltd. 5.64 Million USD 95.567%
Applied Therapeutics, Inc. 9.99 Million USD 97.498%
Hoth Therapeutics, Inc. - USD -Infinity%
BridgeBio Pharma, Inc. 9.3 Million USD 97.313%
BioLineRx Ltd. 4.8 Million USD 94.792%
Atai Life Sciences N.V. 314 Thousand USD 20.382%
VistaGen Therapeutics, Inc. 1.06 Million USD 76.504%
Aurinia Pharmaceuticals Inc. 175.51 Million USD 99.858%
MediciNova, Inc. 1 Million USD 75.0%
Praxis Precision Medicines, Inc. 2.44 Million USD 89.783%
MiMedx Group, Inc. 321.47 Million USD 99.922%
PTC Therapeutics, Inc. 937.82 Million USD 99.973%
Cullinan Oncology, Inc. - USD -Infinity%
Syndax Pharmaceuticals, Inc. - USD -Infinity%
Pasithea Therapeutics Corp. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
4D Molecular Therapeutics, Inc. 20.72 Million USD 98.794%
Dyne Therapeutics, Inc. - USD -Infinity%
Kiniksa Pharmaceuticals, Ltd. 270.25 Million USD 99.907%
Ventyx Biosciences, Inc. - USD -Infinity%
Allakos Inc. - USD -Infinity%
Fulcrum Therapeutics, Inc. 2.8 Million USD 91.087%
Corcept Therapeutics Incorporated 482.37 Million USD 99.948%
BioAtla, Inc. - USD -Infinity%
Allogene Therapeutics, Inc. 95 Thousand USD -163.158%
Larimar Therapeutics, Inc. - USD -Infinity%
Precigen, Inc. 6.22 Million USD 95.984%
BriaCell Therapeutics Corp. - USD -Infinity%
XOMA Corporation 4.75 Million USD 94.746%
Kezar Life Sciences, Inc. 7 Million USD 96.429%
Incyte Corporation 3.69 Billion USD 99.993%
Cara Therapeutics, Inc. 20.96 Million USD 98.808%
Aligos Therapeutics, Inc. 15.52 Million USD 98.39%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
CRISPR Therapeutics AG 371.2 Million USD 99.933%
Akero Therapeutics, Inc. - USD -Infinity%
Eliem Therapeutics, Inc. - USD -Infinity%
EyeGate Pharmaceuticals, Inc. 12.05 Thousand USD -1973.14%
UroGen Pharma Ltd. 82.71 Million USD 99.698%
Sutro Biopharma, Inc. 153.73 Million USD 99.837%
ZIVO Bioscience, Inc. 27.65 Thousand USD -804.159%
Lisata Therapeutics, Inc. - USD -Infinity%
Stoke Therapeutics, Inc. 8.78 Million USD 97.153%
Chimerix, Inc. 324 Thousand USD 22.84%
Outlook Therapeutics, Inc. - USD -Infinity%
60 Degrees Pharmaceuticals, Inc. 253.57 Thousand USD 1.409%
Enanta Pharmaceuticals, Inc. 79.2 Million USD 99.684%
Aprea Therapeutics, Inc. 583.23 Thousand USD 57.135%
Portage Biotech Inc. - USD -Infinity%
OncoCyte Corporation 1.5 Million USD 83.367%
Qualigen Therapeutics, Inc. 5.2 Million USD 95.197%
Cadrenal Therapeutics, Inc. Common Stock - USD -Infinity%
Processa Pharmaceuticals, Inc. - USD -Infinity%
Purple Biotech Ltd. - USD -Infinity%
NextCure, Inc. - USD -Infinity%
ProMIS Neurosciences, Inc. - USD -Infinity%
Dermata Therapeutics, Inc. - USD -Infinity%
Generation Bio Co. 5.9 Million USD 95.766%
Neumora Therapeutics, Inc. Common Stock - USD -Infinity%
Xeris Biopharma Holdings, Inc. 163.91 Million USD 99.847%
TRACON Pharmaceuticals, Inc. 12.04 Million USD 97.924%
NLS Pharmaceutics AG - USD -Infinity%
Mineralys Therapeutics, Inc. - USD -Infinity%
Novavax, Inc. 983.7 Million USD 99.975%
Virios Therapeutics, Inc. - USD -Infinity%
Curis, Inc. 10.02 Million USD 97.506%
Daré Bioscience, Inc. 2.8 Million USD 91.097%
Titan Pharmaceuticals, Inc. 184 Thousand USD -35.87%
Virpax Pharmaceuticals, Inc. - USD -Infinity%
Bicycle Therapeutics plc 26.97 Million USD 99.073%
BeiGene, Ltd. 2.45 Billion USD 99.99%
Kiromic BioPharma, Inc. - USD -Infinity%
Alector, Inc. 97.06 Million USD 99.742%
Protagonist Therapeutics, Inc. 60 Million USD 99.583%
Erasca, Inc. - USD -Infinity%
Checkpoint Therapeutics, Inc. 103 Thousand USD -142.718%
Aura Biosciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
Chemomab Therapeutics Ltd. - USD -Infinity%
Protagenic Therapeutics, Inc. - USD -Infinity%
Pieris Pharmaceuticals, Inc. 42.81 Million USD 99.416%
BioMarin Pharmaceutical Inc. 2.41 Billion USD 99.99%
Histogen Inc. 3.76 Million USD 93.367%
Fortress Biotech, Inc. 84.51 Million USD 99.704%
Avidity Biosciences, Inc. 9.56 Million USD 97.385%
Lyell Immunopharma, Inc. 130 Thousand USD -92.308%
Galecto, Inc. - USD -Infinity%
InMed Pharmaceuticals Inc. 4.59 Million USD 94.563%
Phathom Pharmaceuticals, Inc. 682 Thousand USD 63.343%
Molecular Templates, Inc. 57.3 Million USD 99.564%
PDS Biotechnology Corporation - USD -Infinity%
Amylyx Pharmaceuticals, Inc. 380.78 Million USD 99.934%
Amarin Corporation plc 306.91 Million USD 99.919%
TG Therapeutics, Inc. 233.66 Million USD 99.893%
Aptevo Therapeutics Inc. - USD -Infinity%
Celldex Therapeutics, Inc. 6.88 Million USD 96.368%
Cogent Biosciences, Inc. - USD -Infinity%
Onconetix, Inc. 58.46 Thousand USD -327.606%
MacroGenics, Inc. 58.74 Million USD 99.574%
Y-mAbs Therapeutics, Inc. 84.81 Million USD 99.705%
Ocuphire Pharma, Inc. 19.04 Million USD 98.688%
Adagene Inc. 18.11 Million USD 98.62%
Inhibrx Biosciences, Inc. 1.8 Million USD 86.111%
Cartesian Therapeutics, Inc. 26 Million USD 99.039%
Voyager Therapeutics, Inc. 250 Million USD 99.9%
SciSparc Ltd. 2.87 Million USD 91.316%
Revelation Biosciences, Inc. - USD -Infinity%
Minerva Neurosciences, Inc. - USD -Infinity%
Astria Therapeutics, Inc. - USD -Infinity%
Black Diamond Therapeutics, Inc. - USD -Infinity%
Arcutis Biotherapeutics, Inc. 59.6 Million USD 99.581%
Relay Therapeutics, Inc. 25.54 Million USD 99.021%
Alnylam Pharmaceuticals, Inc. 1.82 Billion USD 99.986%
Psyence Biomedical Ltd. - USD -Infinity%
Artelo Biosciences, Inc. - USD -Infinity%
2seventy bio, Inc. 100.38 Million USD 99.751%
Clene Inc. 654 Thousand USD 61.774%
Boundless Bio, Inc. Common Stock - USD -Infinity%
GeoVax Labs, Inc. - USD -Infinity%
Sonnet BioTherapeutics Holdings, Inc. 147.8 Thousand USD -69.142%
Arbutus Biopharma Corporation 18.14 Million USD 98.622%
Scopus BioPharma Inc. - USD -Infinity%
Absci Corporation 5.71 Million USD 95.628%
XBiotech Inc. - USD -Infinity%
ALX Oncology Holdings Inc. - USD -Infinity%
Lyra Therapeutics, Inc. 1.55 Million USD 83.954%
Entera Bio Ltd. - USD -Infinity%
Trevena, Inc. 3.12 Million USD 92.0%
Adaptimmune Therapeutics plc 60.28 Million USD 99.585%
Caribou Biosciences, Inc. 34.47 Million USD 99.275%
INmune Bio, Inc. 155 Thousand USD -61.29%
Citius Pharmaceuticals, Inc. - USD -Infinity%
Tyra Biosciences, Inc. - USD -Infinity%
Galmed Pharmaceuticals Ltd. - USD -Infinity%
Unity Biotechnology, Inc. - USD -Infinity%
Tenax Therapeutics, Inc. - USD -Infinity%
Jaguar Health, Inc. 9.76 Million USD 97.439%
Clearside Biomedical, Inc. 8.22 Million USD 96.961%
NexImmune, Inc. - USD -Infinity%
Connect Biopharma Holdings Limited - USD -Infinity%
Clearmind Medicine Inc. - USD -Infinity%
Coeptis Therapeutics Holdings, Inc. - USD -Infinity%
Kronos Bio, Inc. 6.28 Million USD 96.024%
Innoviva, Inc. 310.46 Million USD 99.919%
Coherus BioSciences, Inc. 257.24 Million USD 99.903%
Regeneron Pharmaceuticals, Inc. 13.11 Billion USD 99.998%
Bolt Biotherapeutics, Inc. 7.87 Million USD 96.826%
Verastem, Inc. - USD -Infinity%
ProKidney Corp. - USD -Infinity%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Imunon, Inc. - USD -Infinity%
Viking Therapeutics, Inc. - USD -Infinity%
Statera Biopharma, Inc. - USD -Infinity%
ImmunityBio, Inc. 622 Thousand USD 59.807%
Korro Bio, Inc. - USD -Infinity%
Travere Therapeutics, Inc. 145.23 Million USD 99.828%
Kineta, Inc. 5.44 Million USD 95.406%
Catalyst Pharmaceuticals, Inc. 398.2 Million USD 99.937%
Capricor Therapeutics, Inc. 25.17 Million USD 99.007%
GT Biopharma, Inc. - USD -Infinity%
Keros Therapeutics, Inc. 151 Thousand USD -65.563%
Celularity Inc. 22.77 Million USD 98.902%
Crinetics Pharmaceuticals, Inc. 4.01 Million USD 93.77%
CalciMedica, Inc. - USD -Infinity%
Cibus, Inc. 1.81 Million USD 86.241%
C4 Therapeutics, Inc. 20.75 Million USD 98.796%
Marinus Pharmaceuticals, Inc. 30.98 Million USD 99.193%
Eledon Pharmaceuticals, Inc. - USD -Infinity%
Kodiak Sciences Inc. - USD -Infinity%
Sana Biotechnology, Inc. - USD -Infinity%
Annexon, Inc. - USD -Infinity%
Adverum Biotechnologies, Inc. 3.6 Million USD 93.056%
Assembly Biosciences, Inc. 7.16 Million USD 96.51%
Elicio Therapeutics, Inc. - USD -Infinity%
Moderna, Inc. 6.84 Billion USD 99.996%
Vigil Neuroscience, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 787.64 Million USD 99.968%
Vor Biopharma Inc. - USD -Infinity%
Eyenovia, Inc. 3787.00 USD -6501.532%
DiaMedica Therapeutics Inc. - USD -Infinity%
Puma Biotechnology, Inc. 235.63 Million USD 99.894%
Monte Rosa Therapeutics, Inc. - USD -Infinity%
Wave Life Sciences Ltd. 113.3 Million USD 99.779%
Conduit Pharmaceuticals Inc. - USD -Infinity%
ACADIA Pharmaceuticals Inc. 726.43 Million USD 99.966%
Immunocore Holdings plc 249.42 Million USD 99.9%
Tango Therapeutics, Inc. 36.52 Million USD 99.316%
Galectin Therapeutics Inc. - USD -Infinity%
Alkermes plc 1.66 Billion USD 99.985%
Arcellx, Inc. 110.31 Million USD 99.773%
Renovaro Biosciences Inc. - USD -Infinity%
Zentalis Pharmaceuticals, Inc. - USD -Infinity%
Sagimet Biosciences Inc. 2 Million USD 87.5%
Regulus Therapeutics Inc. - USD -Infinity%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -1364.987%
Moolec Science SA 905.04 Thousand USD 72.377%
Biomea Fusion, Inc. - USD -Infinity%
RenovoRx, Inc. - USD -Infinity%
Geron Corporation 237 Thousand USD -5.485%
Mereo BioPharma Group plc 10 Million USD 97.5%
Verrica Pharmaceuticals Inc. 5.12 Million USD 95.121%
Royalty Pharma plc 2.35 Billion USD 99.989%
Atea Pharmaceuticals, Inc. - USD -Infinity%
Greenwich LifeSciences, Inc. - USD -Infinity%
Calithera Biosciences, Inc. - USD -Infinity%
TFF Pharmaceuticals, Inc. 733.87 Thousand USD 65.934%
Mersana Therapeutics, Inc. 36.85 Million USD 99.322%
Humacyte, Inc. - USD -Infinity%
Structure Therapeutics Inc. - USD -Infinity%
NLS Pharmaceutics AG - USD -Infinity%
Genelux Corporation 170 Thousand USD -47.059%
ESSA Pharma Inc. - USD -Infinity%
aTyr Pharma, Inc. 353 Thousand USD 29.178%
Notable Labs, Ltd. 310 Thousand USD 19.355%
Alzamend Neuro, Inc. - USD -Infinity%
Mustang Bio, Inc. - USD -Infinity%
Immunovant, Inc. - USD -Infinity%
Tevogen Bio Holdings Inc. - USD -Infinity%
Vericel Corporation 197.51 Million USD 99.873%
Halozyme Therapeutics, Inc. 829.25 Million USD 99.97%
Akari Therapeutics, Plc - USD -Infinity%
Acasti Pharma Inc. - USD -Infinity%
MiNK Therapeutics, Inc. - USD -Infinity%
Vaxcyte, Inc. - USD -Infinity%
Orgenesis Inc. 530 Thousand USD 52.83%
Spruce Biosciences, Inc. 10.08 Million USD 97.522%
NeuroBo Pharmaceuticals, Inc. - USD -Infinity%
GH Research PLC - USD -Infinity%
Tempest Therapeutics, Inc. - USD -Infinity%
PepGen Inc. - USD -Infinity%
Moleculin Biotech, Inc. - USD -Infinity%
Relmada Therapeutics, Inc. - USD -Infinity%
BriaCell Therapeutics Corp. - USD -Infinity%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Silo Pharma, Inc. 72.1 Thousand USD -246.731%
Telomir Pharmaceuticals, Inc. Common Stock - USD -Infinity%
Belite Bio, Inc - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.898%
XOMA Corporation 4.75 Million USD 94.746%
Reneo Pharmaceuticals, Inc. - USD -Infinity%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Bionomics Limited - USD -Infinity%
Xencor, Inc. 168.33 Million USD 99.851%
Replimune Group, Inc. - USD -Infinity%
Pyxis Oncology, Inc. - USD -Infinity%
Cassava Sciences, Inc. - USD -Infinity%
Vanda Pharmaceuticals Inc. 192.64 Million USD 99.87%
Estrella Immunopharma, Inc. - USD -Infinity%
Turnstone Biologics Corp. 19.3 Million USD 98.705%
Windtree Therapeutics, Inc. - USD -Infinity%
GeoVax Labs, Inc. - USD -Infinity%
MEI Pharma, Inc. 65.29 Million USD 99.617%
Olema Pharmaceuticals, Inc. - USD -Infinity%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -1364.987%
Bio-Path Holdings, Inc. - USD -Infinity%
Enlivex Therapeutics Ltd. - USD -Infinity%
CollPlant Biotechnologies Ltd. 10.95 Million USD 97.719%
scPharmaceuticals Inc. 13.59 Million USD 98.161%
HilleVax, Inc. - USD -Infinity%
Vera Therapeutics, Inc. 1.86 Million USD 86.574%
Tharimmune, Inc. - USD -Infinity%
Genprex, Inc. - USD -Infinity%
SeaStar Medical Holding Corporation - USD -Infinity%
Immunic, Inc. - USD -Infinity%
Atossa Therapeutics, Inc. - USD -Infinity%
Aptorum Group Limited 431.37 Thousand USD 42.046%
Soleno Therapeutics, Inc. - USD -Infinity%
SeaStar Medical Holding Corporation - USD -Infinity%
OKYO Pharma Limited - USD -Infinity%
Carmell Therapeutics Corporation - USD -Infinity%
Achieve Life Sciences, Inc. - USD -Infinity%
Ocean Biomedical, Inc. - USD -Infinity%
Amicus Therapeutics, Inc. 399.35 Million USD 99.937%
Salarius Pharmaceuticals, Inc. - USD -Infinity%
bluebird bio, Inc. 29.49 Million USD 99.152%
DBV Technologies S.A. 15.72 Million USD 98.41%
Compugen Ltd. 33.45 Million USD 99.253%
Protagenic Therapeutics, Inc. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD 32.043%
Vincerx Pharma, Inc. - USD -Infinity%
Fresh Tracks Therapeutics, Inc. 8 Million USD 96.877%
Sensei Biotherapeutics, Inc. - USD -Infinity%
Orchestra BioMed Holdings, Inc. 2.76 Million USD 90.942%
Zevra Therapeutics, Inc. 27.46 Million USD 99.09%
Acrivon Therapeutics, Inc. Common Stock - USD -Infinity%
Benitec Biopharma Inc. 216 Thousand USD -15.741%
Spyre Therapeutics, Inc. 886 Thousand USD 71.783%
Adicet Bio, Inc. - USD -Infinity%
Prime Medicine, Inc. - USD -Infinity%
Aditxt, Inc. 645.17 Thousand USD 61.251%
Madrigal Pharmaceuticals, Inc. - USD -Infinity%
Estrella Immunopharma, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD 76.895%
GlycoMimetics, Inc. 10 Thousand USD -2400.0%
PolyPid Ltd. - USD -Infinity%
Aileron Therapeutics, Inc. - USD -Infinity%
Invivyd, Inc. - USD -Infinity%
Quoin Pharmaceuticals, Ltd. - USD -Infinity%
Rigel Pharmaceuticals, Inc. 116.88 Million USD 99.786%
CorMedix Inc. - USD -Infinity%
Instil Bio, Inc. - USD -Infinity%
Recursion Pharmaceuticals, Inc. 44.57 Million USD 99.439%
Contineum Therapeutics, Inc. Class A Common Stock 50 Million USD 99.5%
Finch Therapeutics Group, Inc. 107 Thousand USD -133.645%
Spero Therapeutics, Inc. 96.73 Million USD 99.742%
Alpha Tau Medical Ltd. - USD -Infinity%
AbCellera Biologics Inc. 38.02 Million USD 99.343%
Ocular Therapeutix, Inc. 58.44 Million USD 99.572%
Surrozen, Inc. - USD -Infinity%
Janux Therapeutics, Inc. 8.08 Million USD 96.907%
Verona Pharma plc - USD -Infinity%
Terns Pharmaceuticals, Inc. - USD -Infinity%
Vir Biotechnology, Inc. 86.18 Million USD 99.71%
Evaxion Biotech A/S 73.11 Thousand USD -241.941%
Verve Therapeutics, Inc. 11.75 Million USD 97.874%
Shattuck Labs, Inc. 1.65 Million USD 84.912%
AlloVir, Inc. - USD -Infinity%
BioVie Inc. - USD -Infinity%
Codexis, Inc. 70.14 Million USD 99.644%
SELLAS Life Sciences Group, Inc. - USD -Infinity%
Lexaria Bioscience Corp. 226.2 Thousand USD -10.518%
Agenus Inc. 156.31 Million USD 99.84%
Virax Biolabs Group Limited 156.41 Thousand USD -59.827%
Lantern Pharma Inc. - USD -Infinity%
Viridian Therapeutics, Inc. 314 Thousand USD 20.382%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Immix Biopharma, Inc. - USD -Infinity%
Celcuity Inc. - USD -Infinity%
Cardiff Oncology, Inc. 488 Thousand USD 48.77%
Acumen Pharmaceuticals, Inc. - USD -Infinity%
IN8bio, Inc. - USD -Infinity%
Avenue Therapeutics, Inc. - USD -Infinity%
Trevi Therapeutics, Inc. - USD -Infinity%
Lexicon Pharmaceuticals, Inc. 1.2 Million USD 79.236%
Liquidia Corporation 17.48 Million USD 98.57%
Quantum-Si incorporated 1.08 Million USD 76.895%
Pasithea Therapeutics Corp. - USD -Infinity%
Xenon Pharmaceuticals Inc. - USD -Infinity%
Sol-Gel Technologies Ltd. 1.55 Million USD 83.912%
United Therapeutics Corporation 2.32 Billion USD 99.989%
Solid Biosciences Inc. - USD -Infinity%
Immuneering Corporation - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
uniQure N.V. 15.84 Million USD 98.422%
Xilio Therapeutics, Inc. - USD -Infinity%
Enveric Biosciences, Inc. - USD -Infinity%
Poseida Therapeutics, Inc. 64.7 Million USD 99.614%
Longboard Pharmaceuticals, Inc. - USD -Infinity%
PMV Pharmaceuticals, Inc. - USD -Infinity%
Elevai Labs, Inc. Common Stock 1.71 Million USD 85.402%
Cue Biopharma, Inc. 5.49 Million USD 95.446%
Nuvectis Pharma, Inc. - USD -Infinity%
ARS Pharmaceuticals, Inc. 30 Thousand USD -733.333%
Zura Bio Limited - USD -Infinity%
Forte Biosciences, Inc. - USD -Infinity%
Elevation Oncology, Inc. - USD -Infinity%
Conduit Pharmaceuticals Inc. - USD -Infinity%
Immunome, Inc. 14.01 Million USD 98.217%
Compass Therapeutics, Inc. - USD -Infinity%
enGene Holdings Inc. Warrants - USD -Infinity%
Inovio Pharmaceuticals, Inc. 832.01 Thousand USD 69.952%
LENZ Therapeutics, Inc. - USD -Infinity%
Altimmune, Inc. 426 Thousand USD 41.315%
Milestone Pharmaceuticals Inc. 1 Million USD 75.0%
Rallybio Corporation - USD -Infinity%
Plus Therapeutics, Inc. 4.91 Million USD 94.911%
Dianthus Therapeutics, Inc. 2.82 Million USD 91.154%
Moolec Science SA 905.04 Thousand USD 72.377%
Anebulo Pharmaceuticals, Inc. - USD -Infinity%
XTL Biopharmaceuticals Ltd. - USD -Infinity%
Tourmaline Bio, Inc. - USD -Infinity%
NeurAxis, Inc. 2.46 Million USD 89.838%
Maravai LifeSciences Holdings, Inc. 288.94 Million USD 99.913%
Lumos Pharma, Inc. 2.05 Million USD 87.811%
enGene Holdings Inc. Common Stock - USD -Infinity%
180 Life Sciences Corp. - USD -Infinity%
NKGen Biotech, Inc. Warrants - USD -Infinity%
Opiant Pharmaceuticals, Inc. 40.72 Million USD 99.386%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Nutriband Inc. 2.08 Million USD 88.011%
CG Oncology, Inc. Common stock 204 Thousand USD -22.549%
argenx SE 1.22 Billion USD 99.98%
Neurogene Inc. - USD -Infinity%
Mirum Pharmaceuticals, Inc. 186.37 Million USD 99.866%
Kintara Therapeutics, Inc. - USD -Infinity%
CervoMed Inc. 7.14 Million USD 96.501%
CARGO Therapeutics, Inc. Common Stock - USD -Infinity%
Sesen Bio, Inc. 40 Million USD 99.375%
AnaptysBio, Inc. 17.15 Million USD 98.543%
Design Therapeutics, Inc. - USD -Infinity%
Leap Therapeutics, Inc. - USD -Infinity%
Seelos Therapeutics, Inc. 2.2 Million USD 88.652%
Achilles Therapeutics plc - USD -Infinity%
NeuroSense Therapeutics Ltd. - USD -Infinity%
ORIC Pharmaceuticals, Inc. - USD -Infinity%
Fractyl Health, Inc. Common Stock 120 Thousand USD -108.333%
Rani Therapeutics Holdings, Inc. - USD -Infinity%
MoonLake Immunotherapeutics - USD -Infinity%
Beam Therapeutics Inc. 377.7 Million USD 99.934%
AEON Biopharma, Inc. - USD -Infinity%
Enliven Therapeutics, Inc. - USD -Infinity%
Kiora Pharmaceuticals, Inc. - USD -Infinity%
Iovance Biotherapeutics, Inc. 1.18 Million USD 78.974%
Taysha Gene Therapies, Inc. 15.45 Million USD 98.382%
Athira Pharma, Inc. - USD -Infinity%
Vaccinex, Inc. 570 Thousand USD 56.14%
HCW Biologics Inc. 2.84 Million USD 91.203%
XOMA Corporation 4.75 Million USD 94.746%
Nektar Therapeutics 90.12 Million USD 99.723%
Arvinas, Inc. 78.5 Million USD 99.682%
Tevogen Bio Holdings Inc. - USD -Infinity%
Merus N.V. 43.94 Million USD 99.431%
Omega Therapeutics, Inc. 3.09 Million USD 91.92%
Quince Therapeutics, Inc. - USD -Infinity%
Rezolute, Inc. - USD -Infinity%
Clene Inc. 654 Thousand USD 61.774%
Indaptus Therapeutics, Inc. - USD -Infinity%
BeyondSpring Inc. 1.75 Million USD 85.722%
Synlogic, Inc. 3.37 Million USD 92.584%
Allarity Therapeutics, Inc. - USD -Infinity%
Phio Pharmaceuticals Corp. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD 32.043%
Werewolf Therapeutics, Inc. 19.94 Million USD 98.746%
Krystal Biotech, Inc. 50.69 Million USD 99.507%
Karyopharm Therapeutics Inc. 146.03 Million USD 99.829%
SpringWorks Therapeutics, Inc. 5.44 Million USD 95.41%
Lipella Pharmaceuticals Inc. 449.61 Thousand USD 44.397%
MannKind Corporation 198.96 Million USD 99.874%
Ikena Oncology, Inc. 9.16 Million USD 97.271%
Cyclerion Therapeutics, Inc. - USD -Infinity%
Gyre Therapeutics, Inc. 113.45 Million USD 99.78%
Gossamer Bio, Inc. - USD -Infinity%
CohBar, Inc. - USD -Infinity%
Cognition Therapeutics, Inc. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
Legend Biotech Corporation 285.14 Million USD 99.912%
Mural Oncology plc - USD -Infinity%
Biora Therapeutics, Inc. 4000.00 USD -6150.0%
PaxMedica, Inc. Common Stock - USD -Infinity%
Disc Medicine, Inc. - USD -Infinity%
Champions Oncology, Inc. 50.15 Million USD 99.502%
REGENXBIO Inc. 90.24 Million USD 99.723%
Ensysce Biosciences, Inc. 2.23 Million USD 88.792%
Anavex Life Sciences Corp. - USD -Infinity%
Cellectar Biosciences, Inc. - USD -Infinity%
Edgewise Therapeutics, Inc. - USD -Infinity%
Vaxart, Inc. 7.37 Million USD 96.612%
PharmaCyte Biotech, Inc. - USD -Infinity%
Aldeyra Therapeutics, Inc. - USD -Infinity%
Cellectis S.A. 755 Thousand USD 66.887%
Longeveron Inc. 709 Thousand USD 64.739%
Repare Therapeutics Inc. 51.13 Million USD 99.511%
Sarepta Therapeutics, Inc. 1.24 Billion USD 99.98%
Inozyme Pharma, Inc. - USD -Infinity%
Revolution Medicines, Inc. 11.58 Million USD 97.841%
Nymox Pharmaceutical Corporation - USD -Infinity%
Third Harmonic Bio, Inc. - USD -Infinity%
ArriVent BioPharma, Inc. Common Stock - USD -Infinity%
AN2 Therapeutics, Inc. - USD -Infinity%
Anixa Biosciences, Inc. 210 Thousand USD -19.048%
Vertex Pharmaceuticals Incorporated 9.86 Billion USD 99.997%
Denali Therapeutics Inc. 330.53 Million USD 99.924%
Revelation Biosciences, Inc. - USD -Infinity%
Veru Inc. 16.29 Million USD 98.466%
Corvus Pharmaceuticals, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Passage Bio, Inc. - USD -Infinity%
Context Therapeutics Inc. - USD -Infinity%
Exicure, Inc. - USD -Infinity%
Day One Biopharmaceuticals, Inc. - USD -Infinity%
Oramed Pharmaceuticals Inc. 2.7 Million USD 90.751%
Revolution Medicines, Inc. Warrant 11.58 Million USD 97.841%
Scinai Immunotherapeutics Ltd. - USD -Infinity%
Rhythm Pharmaceuticals, Inc. 77.42 Million USD 99.677%
Nuvalent, Inc. - USD -Infinity%
ABVC BioPharma, Inc. 152.43 Thousand USD -64.01%
Carisma Therapeutics, Inc. 14.91 Million USD 98.324%
Unicycive Therapeutics, Inc. 675 Thousand USD 62.963%
OmniAb, Inc. 34.16 Million USD 99.268%
Anew Medical, Inc. - USD -Infinity%
Fennec Pharmaceuticals Inc. 21.25 Million USD 98.824%
Lipocine Inc. -2.85 Million USD 108.769%
Lexeo Therapeutics, Inc. Common Stock - USD -Infinity%
Nautilus Biotechnology, Inc. - USD -Infinity%
SAB Biotherapeutics, Inc. 2.23 Million USD 88.834%
G1 Therapeutics, Inc. 82.51 Million USD 99.697%
Bellerophon Therapeutics, Inc. - USD -Infinity%
Sage Therapeutics, Inc. 86.45 Million USD 99.711%
Ocugen, Inc. 6.03 Million USD 95.858%
Mind Medicine (MindMed) Inc. - USD -Infinity%
Q32 Bio Inc. 1.15 Million USD 78.374%
Brainstorm Cell Therapeutics Inc. - USD -Infinity%
Alumis Inc. Common Stock - USD -Infinity%
Equillium, Inc. 36.08 Million USD 99.307%
Kyverna Therapeutics, Inc. - USD -Infinity%
Coya Therapeutics, Inc. 6 Million USD 95.835%
CNS Pharmaceuticals, Inc. - USD -Infinity%
Galera Therapeutics, Inc. - USD -Infinity%
Evelo Biosciences, Inc. - USD -Infinity%
Comera Life Sciences Holdings, Inc. 633.1 Thousand USD 60.512%
Dominari Holdings Inc. 2.03 Million USD 87.739%
Edesa Biotech, Inc. - USD -Infinity%
vTv Therapeutics Inc. - USD -Infinity%
Bio-Techne Corporation 1.15 Billion USD 99.978%
Agios Pharmaceuticals, Inc. 26.82 Million USD 99.068%
Harmony Biosciences Holdings, Inc. 582.02 Million USD 99.957%
Prelude Therapeutics Incorporated - USD -Infinity%
Candel Therapeutics, Inc. - USD -Infinity%
iTeos Therapeutics, Inc. 12.59 Million USD 98.015%
Nkarta, Inc. - USD -Infinity%
BioCardia, Inc. 477 Thousand USD 47.589%
Iterum Therapeutics plc - USD -Infinity%